Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-08-11

FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (ScieGen Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves a supplemental application for metformin hydrochloride extended-release tablets from ScieGen Pharmaceuticals, Inc., signaling a regulatory acknowle…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Metformin Hydrochloride Extended-release Tablets (metformin hydrochloride extended-release)

Snippet

SUPPL AP for METFORMIN HYDROCHLORIDE (METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS)